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Schistosoma mansoni infection has been associated with an increased HIV prevalence in
humans and SHIV incidence in primate models. We hypothesized that immune activation
from this gastrointestinal mucosa infection would increase highly HIV-susceptible CD4 T
cell subsets in the blood and the foreskin through common mucosal homing.
Methodology/Principal Findings
Foreskin tissue and blood were obtained from 34 HIV- and malaria-uninfected Ugandan
men who volunteered for elective circumcision, 12 of whom were definitively positive for
S.mansoni eggs in stool and 12 definitively negative for both S.mansoni eggs and worm
antigen. Tissue and blood T cell subsets were characterized by flow cytometry and immuno-
histochemistry (IHC). Th17 and Th1 cells from both the blood and foreskin expressed higher
levels of CCR5 and were more activated than other CD4 T cell subsets. S.mansoni-infected
men had a higher frequency of systemic Th1 cells (22.9 vs. 16.5% of blood CD4 T cells,
p<0.05), Th17 cells (2.3 vs. 1.5%, p<0.05), and Th22 cells (0.5 vs. 0.3%, p<0.01) than unin-
fected men. Additionally, Th17 cells in the blood of S.mansoni-infected men demonstrated
enhanced function (28.1 vs. 16.3% producing multiple cytokines, p = 0.046). However,
these immune alterations were not observed in foreskin tissue.
Conclusions/Significance
S.mansoni infection was associated with an increased frequency of highly HIV-susceptible
Th1, Th17 and Th22 cell subsets in the blood, but these T cell immune differences did not
extend to the foreskin. S.mansoni induced changes in T cell immunology mediated through
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the common mucosal immune system are not likely to increase HIV susceptibility in the
foreskin.
Author Summary
Fishing communities in East Africa have a very high prevalence of HIV, and also high
rates of other endemic infections such as malaria and the fluke Schistosoma mansoni. Gen-
ital infections are known to increase HIV susceptibility through the recruitment and acti-
vation of mucosal CD4 T cells to the site of HIV sexual exposure. These activated CD4 T
cells are necessary for an effective host immune response but are also preferentially
infected by HIV. We hypothesized that S.mansoni infection in the gut mucosa might
increase recruitment and activation of HIV target cells at other mucosal sites, and thereby
contribute to high HIV rates in fishing communities. We enrolled men from a fishing
community in Uganda and examined the frequency of highly HIV-susceptible cell types in
their blood and foreskin tissue (a main site of HIV acquisition in heterosexual men). We
found that men with S.mansoni infection had a greater frequency of HIV target cells in
their blood, but not their foreskin tissue, perhaps because foreskin cells did not express
mucosal homing markers. It is possible that HIV target cells observed in the blood of S.
mansoni-infected individuals may traffic to other mucosae, such as the vagina or gut, and
so the possibility that S.mansoni infection increases risk at these sites should be explored.
Introduction
HIV continues to be a public health crisis, with 2.3 million new infections and 1.6 million
HIV-related deaths in 2013. Most new infections (70%) occurred in sub-Saharan Africa (SSA),
where the predominant mode of transmission is heterosexual sex [1]. Despite the high number
of new cases of HIV, the likelihood of transmission during a single sexual exposure is low, and
is almost always established by a single virus quasispecies out of multiple distinct strains in the
transmitting partner [2]. This suggests that the genital mucosa presents a significant barrier to
infection. The substantial heterogeneity in susceptibility between individuals [3, 4] may reflect
differences in the availability of target cells in the genital mucosa [5, 6], and increased levels of
genital immune activation may account for the much higher per-contact risk of acquisition
after exposure in SSA [7, 8].
CD4 T cells expressing the chemokine receptor CCR5 are the predominant targets of HIV
during initial infection [2, 9, 10], and specific CD4+ T helper (Th) subsets are particularly
susceptible to HIV. Activated Th cells are more susceptible to infection [11–13], as are Th17
cells (defined by the production of IL-17 [14]), Th1 cells (produce IFNγ [15]) and Th22 cells
(produce IL-22 in the absence of IL-17 or IFNγ [16–18]). Not only are these subsets more sus-
ceptible to HIV infection in vitro [19–22], but they are also selectively depleted early in HIV
infection [21, 23–25], and are less frequent in HIV-exposed seronegative (HESN) men [26].
Th17 cells have the capacity to not only produce IL-17, but also other pro-inflammatory cyto-
kines, including IL-22 and IFNγ [27, 28]. Polyfunctional Th17 cells are more susceptible to
HIV infection in vitro than either Th1 cells or Th17 cells that produce IL-17 alone [20–22],
and are rapidly depleted in early HIV infection [28]. The mucosal availability of these highly
susceptible CD4 T cells may determine whether exposure to HIV results in infection [5].
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In keeping with the role of these mucosal cell subsets in HIV susceptibility, their numbers
are increased in the genital mucosa by sexually-transmitted infections (STIs) that enhance HIV
risk, such as Herpes simplex virus type 2 (HSV-2) [29–34], even in the absence of clinically
apparent ulceration [35]. Recent studies show that non-genital infections common to SSA,
such as helminthic infections, promote systemic inflammation and CCR5 expression [36–40].
Whether immune activation from infections of the gastrointestinal mucosa, such as helminthic
infections, would translate into genital immune alterations is not known, but immune stimulus
at one mucosal surface often leads to T cell activation and recruitment at distal mucosal sites
through the expression of common mucosal homing markers [41]. This may explain why Ken-
yan women without STIs nonetheless have an increased frequency of activated CD4 T cells in
their cervical mucosa compared to their peers from the United States [8]. While helminthic
infections were not tested for in this study, their high regional prevalence suggests a potential
role in the mucosal immune activation observed in these otherwise healthy women.
HIV disproportionately affects fishing communities in SSA; incidence rates on the shores of
Lake Victoria in Uganda approach 5%, while the national average is under 0.75% [42–44]. Hel-
minthic infections are very common in these fishing communities, with over 60% of men aged
20–29 years infected with Schistosoma mansoni [45], a parasitic worm that causes a chronic
gastrointestinal (GI) infection if untreated and has been associated with increased HIV preva-
lence [46]. During infection, cercariae (free-swimming larval stage) found in contaminated
fresh water penetrate the skin and migrate through the circulation to the portal vein where
they mature into adult worms. Females release approximately 300 eggs per day, which traverse
the walls of the vein and intestine to be released into the gut lumen and excreted [47]. While
the worms themselves evade immune destruction [48], eggs are highly antigenic and not only
require a strong CD4 T cell response for efficient release [49, 50], but also incite the formation
of CD4 T cell-containing granulomas in intestinal tissue [47]. The mechanism for the potential
association between S.mansoni infection and HIV susceptibility is unclear, since S.mansoni
does not directly involve the urogenital mucosa. This is in contrast to S. haematobium (uncom-
mon in the Entebbe region [45]), which involves the urogenital mucosa and therefore alters
mucosal HIV susceptibility directly at the site of sexual exposure [51–53]. However, S.mansoni
infection does result in increased HIV target cells in the blood [54], and rhesus macaques
infected with S.mansoni are 17-times more susceptible to SHIV [55].
Clinical trials of adult circumcision have demonstrated that the foreskin is a major site of
HIV acquisition in uncircumcised heterosexual men [56–58]. We therefore sought to deter-
mine whether S.mansoni infection is associated with alterations in HIV target cells, both sys-
temically, and at this relevant tissue site.
Methods
Study participants
Participants aged 18–49 years were recruited from the Uganda Virus Research Institute- Inter-
national AIDS Vaccine Initiative (UVRI-IAVI) Voluntary HIV Counselling and Testing
(VCT) Clinic in Kasenyi, Uganda, a fishing community on the shore of Lake Victoria. All men
who expressed an interest in voluntary adult medical male circumcision were offered enrol-
ment in the study. Exclusion criteria included current use of immunosuppressive therapy or
infection with malaria. Men who had symptomatic genital infections were to be provided treat-
ment and followed up weekly until resolution of symptoms, at which point they would be
scheduled for circumcision. To avoid stigmatization, both HIV-infected and uninfected men
were offered participation in this study, however, blood and foreskin samples were only ana-
lyzed for HIV-uninfected men. All participants were offered VCT, and HIV-infected men were
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referred to Wagagai Health Center (a private health facility at Kasenyi landing site) for treat-
ment and care. Individuals who tested positive for schistosomiasis were treated at the clinic
with single-dose praziquantel, 40 mg/kg body weight.
Ethics statement
All participants provided written informed consent, and ethical approval was obtained through
the Institutional Review Boards at the Uganda Virus Research Institute and at the University of
Toronto.
Sample collection and diagnostic testing
After VCT, consenting participants completed a behavioural questionnaire and were scheduled
for circumcision. HIV testing was performed according to the Uganda National Algorithm,
consisting of two rapid tests (Alere Determine HIV-1/2, Abbott Laboratories, Matsudo-shi,
Japan; and HIV 1/2 STAT-PAK Dipstick Assay, Chembio Diagnostic Systems, Medford, USA),
with a third rapid (Unigold HIV, Trinity Biotech, Wicklow, Ireland) used for discordant
results. Participants returned to provide stool and terminal urine samples (collection vials from
VWR, Mississauga, Canada) for three consecutive days surrounding surgery (i.e. the day prior
to surgery, the day of surgery, and the day after surgery). Urine was immediately separated,
with 1.5ml reserved for Circulating Cathodic Antigen (CCA) detection (stored at 4°C until
analysis later the same day) and the remainder preserved with 0.2% bleach for S. haematobium
egg detection by light microscopy [59]. Screening for S.mansoni was performed using the
Kato-Katz method [59], with three slides screened per stool sample. Presence of urine-CCA,
which does not distinguish between species of schistosomes and therefore cannot differentiate
S.mansoni from S. haematobium, was detected using the Rapid Medical Diagnostics Schistoso-
miasis Test (Rapid Medical Diagnostics; Pretoria, RSA) according to the manufacturer’s direc-
tions. Previous studies in Rakai have found the Kato Katz method on two stool samples
(sensitivity = 98.6%) or rapid CCA detection in one urine sample (sensitivity = 91.7%, specific-
ity = 75.0%) accurately detect S.mansoni infection [60]. For the purposes of statistical compari-
sons in this study, men were classified as schistosomiasis-positive if they were positive by both
Urine-CCA and had eggs in a stool sample (S.mansoni) on at least one study visit. Men were
considered to be schistosomiasis-negative if negative for both Urine-CCA and eggs at all study
visits.
Circumcisions were performed at the Wagagai Health Center at Kasenyi, Entebbe, Uganda.
Prior to surgery, a clinical officer performed a physical examination and collected 16ml of
whole blood. Surgery was deferred and participants were treated if urethral discharge or genital
ulceration were present. Foreskins were collected into RPMI 1640 media supplemented with:
10% heat-inactivated FBS, 10U/ml penicillin, 10μg/ml streptomycin, 250ng/ml amphotericin
B, and 2mM L-Glutamine (all from Gibco, Invitrogen; Carlsbad, CA, USA; henceforth referred
to as R10 medium). Blood and foreskin samples were transported to UVRI-IAVI laboratories
for immediate processing: four sections of foreskin were snap frozen into cryomolds in Opti-
mal Cutting Temperature (OCT) compound (Fisher Scientific, Toronto, Canada) for immuno-
histochemistry (IHC); and one large section was reserved for T cell isolation. An aliquot of
whole blood was removed for malaria diagnostics, and the remainder was separated into
plasma and PBMC fractions by density gradient centrifugation (Ficoll-Paque Plus; Amersham
Biosciences; Uppsala, Sweden). Participants were confirmed to be negative for malaria using
both the Cypress Diagnostics Malaria falciparum Rapid Test (Langdorp, Belgium) and by
microscopy (Giemsa stained thick smear). HSV-2 serology was performed by ELISA (Herpes
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Simplex Type 2 IgG ELISA, Kalon Biological Ltd., Guildford, UK), as previously validated in
Uganda [61]. PBMCs were reserved for flow cytometry.
T cell isolation from the foreskin
T cells were isolated from foreskin tissue as previously described [62]. Briefly, tissue was dis-
rupted by a combination of mechanical and enzymatic digestion with 1.0ml of 500U/ml Colla-
genase Type I (Gibco, Invitrogen; Carlsbad, CA, USA) in the presence of 50U/ml of DNAse
(Invitrogen). The resulting cell suspension was filtered through a 100μm cell strainer (BD Bio-
sciences; Franklin Lakes, NJ USA) to remove any remaining undigested tissue. Filtered cells
were allowed to rest under normal growth conditions (37°C, 5% CO2, humidified atmosphere)
for 3–7 hours.
Characterization of T cell subsets
PBMC and foreskin mononuclear cell counts were determined by trypan blue exclusion.
1x106 PBMCs and 10-20x106 foreskin mononuclear cells (depending on yield) were plated
in 500μl culture medium with 5μg/ml Brefeldin A (GolgiPlug, BD Biosciences) and fluoro-
chrome-labelled CCR6 antibody (11A9; BD Biosciences). Cells were stimulated for 9 hours at
37°C with either: 0.5ng/ml phorbol-12-myristate-13-acetate (PMA) and 0.5μg/ml ionomycin;
2μg/ml Staphylococcal enterotoxin B (SEB); or vehicle (0.1% Dimethyl sulfoxide, DMSO; all
from Sigma; St. Louis, MO, USA). After stimulation, samples were washed with cold 2% Foetal
Bovine Serum (FBS) in phosphate buffered saline (PBS) and stained with LIVE/DEAD Fixable
Aqua Dead Cell Stain Kit (Life Technologies, Burlington, Canada), washed and then stained
with fluorochrome-labeled monoclonal antibodies specific for the following surface antigens:
CD3 Qdot655 (S4.1), CD4 PE-Cy7 (SK3), CCR5 PE-Cy5 (2D7/CCR5), CD69 APC-Cy7
(FN50), HLA-DR PE-CF594 (G46-6), and CD38 AF700 (HIT2; all BD Biosciences). In a sec-
ond aliquot of cells, cells were stained for homing integrin α4 FITC (9F10), β7 APC (FIB504;
both BD) and Cutaneous Lymphocyte Antigen (CLA) PE (HECA-452, Miltenyi Biotec; San
Diego, CA, USA) in addition to CD3 and CD4. Samples were then washed and permeabilized
using the eBioscience fixation/permeabilization solution (eBiosciences; San Diego, CA, USA)
and stained with fluorochrome-labeled monoclonal antibodies specific for the following
intracellular cytokines: IFNγ V450 (B27; BD Biosciences), IL17A AF488 (eBio64DEC17;
eBioscience), and IL22 PE (22URTI; eBioscience). Data were acquired using an LSRII flow
cytometer (BD Biosciences).
CD3 density quantification by immunohistochemistry
All flow cytometry data were analyzed as relative proportions of CD3+ T cells. To determine if
the overall density of CD3 T cells varied between men, as opposed to the relative abundance of
specific subsets, the average number of T cells per mm2 of tissue was determined using IHC
staining for CD3. OCT-cryopreserved tissues were sectioned to 5μm, fixed in acetone, and fro-
zen for batch staining. At the time of staining, frozen sections were thawed and air-dried at
room temperature. Sections were blocked with 10% normal goat serum and stained with rabbit
anti-human CD3 antibody (Dako, Carpinteria, CA, USA) followed by goat anti-rabbit second-
ary antibody conjugated to AF647 (Life Technologies). Slides were then washed with PBS,
counter stained with Hoechst DAPI, and air-dried. The number of CD3+ T cells per mm2 of
tissue for each patient was derived from the average of four tissue sections: two from separate
locations on the distal edge of the foreskin, and two from the proximal edge. A median of
6.10mm2 of foreskin tissue was analyzed by IHC per patient. Whole sections were scanned at
0.5μm/pixel using the TissueScope 4000 (Huron Technologies, Waterloo, Canada). Image
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analysis software (Definiens, München, Germany) was used to delineate the apical edge of the
epidermis of the entire length of each section to a depth of 300μm (excluding artefacts or
folds). CD3 cells were defined as nuclear DAPI fluorescence overlapping with, or directly adja-
cent to, AF647 fluorescence. The average density of CD3+ cells/mm2 of foreskin tissue was
then multiplied by the percentage of CD3+ cells found to co-express CD4 by flow cytometry to
calculate the average number of CD4 T cells per mm2 of foreskin tissue.
Statistical analysis
Flow cytometry data was analyzed in FlowJo v.9.8.2 (Treestar; Ashland, OR, USA). Expression
of surface markers was compared between Th subsets using the Friedman chi-square test; with
post-hoc pairwise comparisons made using the Wilcoxon related samples rank test; Bonferroni
adjusted p-values are reported. T cell populations were compared between S.mansoni-infected
and uninfected men by Mann-Whitney U test. Analysis of Th17 cell polyfunctionality was per-
formed using Boolean gating in FlowJo software, and polyfunctionality compared between S.
mansoni-infected and uninfected men with a chi-squared distribution (1000 permutations of
pies) using SPICE v5.35 software (Exon, National Institute of Allergy & Infectious Diseases)
[63]. Post-hoc comparisons between functional Th17 subsets were made using related samples
Wilcoxon rank test. Excel v.14.4.8 (Microsoft; Redmond, WA, USA) was used prior to statisti-
cal testing, and statistical tests were run using SPSS v.20.0 for Mac (IBM; New York, NY, USA).
Based on previous foreskin T cell studies [26, 62, 64], a sample size of 34 men provided 80%
power to detect a difference of one standard deviation in the proportion of either foreskin or
blood CD4 T cells that were Th17 cells (α = 0.05).
Results
Study population
Participants consisted of 34 HIV-uninfected men living in fishing communities on the shores
of Lake Victoria who were undergoing elective adult circumcision for HIV prevention. No par-
ticipant tested positive for malaria, had a symptomatic genital infection, or was taking immu-
nosuppressive therapy at the time of enrolment. As the immunopathology of schistosomiasis is
the result of egg production, and not necessarily the presence of worms, we compared men
with documented S.mansoni egg production on at least one of the three days surrounding sur-
gery (n = 12; median 918 eggs per gram (epg); IQR 108–4644 epg) to control men who were
free of both eggs and CCA in urine (an antigen originating from the gut of mature worms) for
three consecutive days surrounding surgery (n = 12). No S. haematobium eggs were detected in
any participant. Men who had detectable Urine-CCA but who were not shedding eggs (n = 10)
were included graphically in the Th17 functional analysis, but were excluded from statistical
analysis. S.mansoni-infected and control men were of similar age, HIV-risk taking behaviour
(based on self-reported condom use, recent number of sexual partners, and transactional sex),
and HSV-2 serostatus (Table 1). However, S.mansoni infection was associated with employ-
ment in the fishing industry (p = 0.04) and more frequent contact with lake water (p = 0.03).
Characterization of HIV target cell populations in the foreskin and blood
We first characterized Th1, Th17, and Th22 cells, independent of S.mansoni infection status,
to test our assumption that these three Th subsets are preferential HIV targets. We examined
expression levels of markers known to be associated with HIV susceptibility, namely the HIV
co-receptor CCR5 [10, 65] and activation markers CD69 [65, 66] and HLA-DR [11, 66–68] on
these Th subsets in the blood and foreskin of all 34 men.
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CCR5 expression levels were decreased after PMA/iono stimulation (median 1.4% CCR5
+ of CD4 T cells after PMA/iono vs. 3.2% on unstimulated), and so we report expression levels
on functional subsets defined using SEB stimulation. Gating strategy and representative plots
of stimulated cells are shown in Fig 1. Th subset definitions were mutually exclusive and
exhaustive: Th17 cells produced IL-17A, and either IFNγ or IL-22; Th1 cells produced IFNγ,
but not IL-17A; Th22 cells produced IL-22, but not IL-17A or IFNγ; and “other CD4 T cells”
(the comparator group) were Th cells that did not produce any of these three cytokines upon
stimulation (Fig 1).
In the blood, all three Th subsets (Th1, Th17 and Th22) were more likely to express the
HIV co-receptor CCR5 than other CD4 T cells (other CD4 T cells: 2.8%; all p<0.001; Fig 2A),
although there were no significant differences between Th subsets (Th17: 10.8%; Th22: 7.1%;
Th1: 6.3%). All three subsets also expressed higher levels of activation markers CD69 and
HLA-DR compared to other CD4 T cells (other CD4 T cells: 31.1% CD69+, Fig 2B; and 20.0%
HLA-DR+, Fig 2C; all p<0.001). Th17 and Th1 cells had substantially higher levels of both
activation markers (87.9 and 86.0% CD69+, respectively; 43.4 and 45.9% HLA-DR+, respec-
tively); Th22 cells were also more activated than other CD4 cells (60.5% CD69+ and 35.8%
HLA-DR+, p<0.001), albeit less so that Th1 or Th17 cells (both p<0.001).
In the foreskin, Th1 and Th17 cells expressed significantly higher levels of CCR5 than other
CD4 T cells (61.1% and 52.6% vs. 42.7%, both p<0.001; Fig 2A). In contrast to the blood, Th22
cells expressed no more CCR5 than other CD4 T cells (39.0 vs. 42.7%, ns). Also in contrast to
the blood, foreskin Th1 cells expressed significantly more CCR5 than Th17 cells (p<0.001).
Expression of HLA-DR on foreskin Th subsets followed a similar pattern, with Th1 cells
expressing highest levels (69.4%; p<0.001 vs. other CD4 T cells and Th17 cells), followed by
Th17 cells (59.1%, p<0.001 vs. other CD4 T cells), and Th22 cells having similar expression to
other CD4 T cells (51.6% and 48.8%, respectively; Fig 2B). All three Th populations of interest
had higher CD69 expression than other CD4 T cells (other CD4 T cells: 58.1%, all p<0.001; Fig
2B), with Th17 and Th1 cells having higher levels (both 94.0%) than Th22 cells (68.7%;
p<0.001). In a separate flow cytometry panel, we assessed the expression of gut and skin hom-
ing markers on foreskin and blood CD4 T cells. We found the foreskin to be enriched for CD4
T cells expressing the skin homing marker CLA compared to the blood (59.8% of foreskin CD4
T cells vs. 18.2% of blood, p<0.001), but to have significantly reduced expression of the muco-
sal homing marker α4β7 (3.2% vs. 6.8%, p<0.001; S1 Fig).
Table 1. Participant demographics.
S. mansoni Uninfected
(n = 12) (n = 12) p-value
Age (yrs) 26.7 (18–37) 22.4 (18–31) ns
HSV-2 Seropositive (%) 33.3 8.4 ns
Sex Partners Last 6 Months (#) 1.3 (0–3) 1.1 (0–4) ns
Using Condoms
Never 66.7 58.3
Sometimes 8.4 16.7 ns
Always 25.0 25.0
Works in the fishing industry (%) 58.3 0.0 0.037
Contact with lake > weekly (%) 58.3 8.4 0.027
Every treated for schistosomiasis (%) 16.7 8.4 ns
doi:10.1371/journal.pntd.0004067.t001
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HIV target cell proportional frequency and absolute number in S.
mansoni-infected and uninfected men
S.mansoni-infected men had significantly higher frequencies of Th1 (22.9 vs. 16.5% of CD4 T
cells, p<0.05; Fig 3A), Th17 (2.3 vs. 1.5%, p<0.05) and Th22 (0.5 vs. 0.3%, p<0.01) cells in
their blood compared to uninfected men. However, these differences did not extend to the fore-
skin, since S.mansoni-infected and uninfected men had similar frequencies of susceptible Th
populations in foreskin tissue. We also did not observe significant differences in overall CD4 T
cell expression of CCR5, CD69 or HLA-DR between S.mansoni-infected and uninfected men,
in either the blood or foreskin (Fig 3B). While flow cytometry provides the proportion (%) of
CD3 T cells expressing markers of interest, it does not provide information on the total number
of T cells present in the tissue. Using IHC to determine the number of CD3 T cells per mm2 of
tissue, we found no statistically significant difference in the average density of foreskin CD3+-
cells (262/mm2 (IQR 134-471/mm2) vs. 191/mm2 (IQR 125-533/mm2); p = 0.52) in S.man-
soni-infected and uninfected men.
Impact of S.mansoni infection on Th17 cell function
We then went on to compare the functional capacity of Th17 cells, defined as their ability to
co-produce IL-22 and/or IFNγ in addition to IL-17A, between S.mansoni-infected and unin-
fected men. Th17 cells from the blood of men infected with S.mansoni had a greater capacity
to produce pro-inflammatory cytokines than those from uninfected men (Fig 4A, p = 0.046).
Fig 1. Flow cytometry gating strategy for Th subsets isolated from (A) the blood and (B) the foreskin. Blood cells were isolated by density
centrifugation, and foreskin cells by mechanical and enzymatic digestion of tissue. Dead cells and doublets were excluded. Lymphocytes were identified
based on characteristic size and granularity in blood samples and gates applied to foreskin samples. CD4 T cells were identified by expression of CD3 and
CD4. Th subsets among CD4 T cells were identified by cytokine production in response to non-specific stimuli (SEB shown). Gates for cytokine production
were based on unstimulated samples. Th17 cells were identified by production of IL-17A; Th1 cells by production of IFNγ and not IL-17A; Th22 cells by
production of IL-22 in the absence of either IFNγ or IL-17A. Representative plots showing expression of CCR5, CD69 and HLA-DR on CD4 T cells are also
shown.
doi:10.1371/journal.pntd.0004067.g001
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Post-hoc analysis performing pairwise comparisons showed trends to increased numbers of tri-
ple cytokine producing cells (2.7 vs. 0.92%, p = 0.059) and IFNγ-producing Th17 cells (13.4 vs.
8.6%, p = 0.104), and significantly increased IL-22 producing Th17 cells (10.1 vs. 4.4%,
p = 0.013; Fig 4B) in S.mansoni-infected men.
Discussion
The likelihood of infection after sexual exposure to HIV is heterogeneous and likely deter-
mined by availability of susceptible CD4 T cells at the site of exposure [6]. Activated CD4 T
cells [11–13] and Th1, Th17 [19–24], and Th22 [25] subsets have been implicated as preferen-
tial targets of HIV, and their frequency at mucosal sites may be altered by co-infections. In
keeping with the hypothesis that these Th cell subsets represent preferential HIV targets, they
demonstrated an elevated expression of the HIV co-receptor CCR5, and were more likely to
express activation markers CD69 and HLA-DR, markers associated with increased HIV cellu-
lar entry [65]. Not only did we find that S.mansoni infection was associated with an increased
systemic (blood) frequency of Th1, Th17 and Th22 cells, but functional analysis of blood Th17
cells demonstrated that S.mansoni infection was associated with increased production of pro-
Fig 2. Differential expression of markers of HIV susceptibility on Th populations isolated from the blood and foreskin. Expression of (A) CCR5, (B)
CD69, and (C) HLA-DR was measured on CD4 T cells isolated from the blood (PBMCs) and foreskin tissue using flow cytometry. “Other” refers to CD4+/CD3
+ cells that do not produce IL-17A, IFNγ or IL-22. Expression of surface markers on Th subsets was compared using the Friedman chi-square test; post-hoc
pairwise comparisons made using Wilcoxon related samples rank test and Bonferroni adjusted p-values are reported (*p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004067.g002
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inflammatory cytokines IL-22 and IFNγ, a characteristic associated with selective depletion
during HIV infection [25]. However, the systemic immune impact of S.mansoni infection did
not extend to the foreskin. Specifically, we found no difference in the frequency of Th1, Th17
or Th22 cells, or in immune activation or CCR5 expression, between the foreskins of S.man-
soni-infected and uninfected men. Of note, Th subsets in the foreskin had a different pattern of
CCR5, HLA-DR and CD69 expression compared to blood, with Th22 cells at this site having
lower CCR5 expression and activation status than Th1/Th17 subsets.
Our observation of increased systemic CD4 T cell activation is consistent with the known
immunopathology of S.mansoni. A robust CD4 T cell response is essential for egg excretion
during S.mansoni infection, demonstrated by the observations that egg excretion does not
occur in immunocompromised mice [69, 70] or humans [50]. Eggs may also become trapped
in the tissue on their way to being excreted [71], and the development of granulomatous lesions
around them is dependent on CD4 T cells [72, 73]. While early studies in mice attributed the
immunopathology of schistosomiasis infection to IFNγ production and Th1 activation [74,
75], the identification of Th17 cells as a distinct Th subset [76] led to the observation that Th17
cells were integral to granuloma formation, and high levels of IL-17A were produced by granu-
loma cells [77, 78]. Our findings of increased frequencies of Th1 and Th17 cells in the blood of
S.mansoni-infectedmen is consistent with these previous observations. To our knowledge
Th22 cells have not been studied in the setting of S.mansoni infection, but since they play a
role in the maintenance of intestinal epithelial integrity [18, 25, 79] we hypothesize that the
Fig 3. HIV target cells in the blood and foreskin of men infected with S.mansoni. HIV target cells were
identified by flow cytometry from cells isolated from the blood (PBMC) or foreskin, and were compared
between men shedding S.mansoni eggs (hatched bars) and men who were free of Schistosoma infection
(clear bars). (A) Proportions of CD4 T cells that are Th1, Th17 or Th22 cells. (B) Expression of markers of HIV
susceptibility on CD4 T cells. T cell populations were compared between S.mansoni-infected and uninfected
men by Mann-Whitney U test (*p<0.05; **p<0.01).
doi:10.1371/journal.pntd.0004067.g003
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increase we observed during S.mansoni infection may be in response to the inflammatory foci
that form in the intestinal epithelium during egg excretion.
Th17 and Th1 cells are highly susceptible to HIV in vitro, with IFNγ-producing Th17 cells
(elevated in S.mansoni-infected men in the current work) being particularly susceptible [20–
22], and Th22 cells may also be more susceptible [25]. However, the increased frequency of the
highly susceptible Th subsets that we observed in the blood of S.mansoni-infectedmen was not
observed in foreskin tissue. Since the foreskin is the primary site of HIV acquisition in hetero-
sexual Ugandan men, the potential impact of these systemic S.mansoni-associated immune
changes on HIV susceptibility in heterosexual men is not clear. This is in keeping with two
recent publications that found no association between S.mansoni infection and either HIV
incidence [80] or prevalence [81] in Entebbe, Uganda. However, our findings do emphasize the
need for tissue specific studies when assessing the potential impact of co-infections on HIV
susceptibility. This need was further demonstrated by the different patterns of CCR5 expres-
sion observed on Th subsets in the blood compared to foreskin: while blood CCR5 expression
would suggest that Th22 cells were more HIV-susceptible than Th1 cells, foreskin Th22 cells
had relatively low CCR5 expression.
Fig 4. Functional capacity of Th17 cells isolated from the blood of men infected with S.mansoni. The
ability of Th17 cells isolated from the blood to produce a second or third cytokine (IL-22 and/or IFNγ in
addition to IL-17A) in response to non-specific stimulation (PMA/iono) was measured using flow cytometry.
(A) Proportion of Th17 cells producing additional cytokines was compared between men infected with S.
mansoni (shedding eggs), intermediate (presence of worms detected by Urine-CCA, but not shedding eggs),
and uninfected men (no detection of worm antigen or eggs). Assessment of polyfunctionality was performed
using SPICE v5.35 software with polyfunctionality compared between S.mansoni-infected and uninfected
men using a chi-squared distribution (1000 permutations of pies)[63]. (B) Post-hoc comparison of individual
functional subsets between S.mansoni-infected (hatched bars) and uninfected men (related samples
Wilcoxon rank test).
doi:10.1371/journal.pntd.0004067.g004
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We had hypothesized that S.mansoni infection would alter HIV target cells in the foreskin
through activation of the common mucosal immune system. Local gut epithelial damage
occurs during S.mansoni egg excretion and would be expected to directly increase the fre-
quency of HIV target cells at this site, likely explaining the increased susceptibility to SHIV
seen in S.mansoni-infected primates after rectal but not systemic virus challenge [55]. How-
ever, we had speculated that the upregulation of common mucosal T cell homing molecules,
such as the integrin α4β7 [82, 83], might also increase T cell activation and HIV target cell num-
bers at genital mucosal sites. One reason that we did not observe this may be that T cells in the
foreskin expressed high levels of the skin homing marker CLA, but not α4β7.
This study had two limitations that should be considered. The first is the relatively small
sample size. This study was designed to determine if a larger, prospective study of the effect of
S.mansoni infection on foreskin immunology was warranted. It was powered to detect a differ-
ence of one standard deviation in Th populations between groups, and so more subtle chances
in foreskin T cell immunology would be missed. However, the robust immune differences seen
in the blood without consistent trends in the foreskin suggest that a larger sample size would
not change our conclusions. A second limitation of this study was the lack of diagnostic testing
for STIs other than HSV-2. Genital co-infections are associated with local mucosal immune
activation [33], and therefore if they were overrepresented among control men (S.mansoni-
uninfected), this would have contributed to the absence of S.mansoni-associated foreskin
immune changes in this study. However, since there was a non-significant trend to increased
HSV-2 prevalence in S.mansoni-infected men, it seems unlikely that these same men had sig-
nificantly lower rates of other STIs. Furthermore, since HSV-2 infection is associated with T
cell activation in the foreskin but not blood [35], it is not likely that inter-group differences in
STI prevalence explain the presence of T cell immune alterations in the blood.
In conclusion, we found that S.mansoni infection in HIV-uninfected Ugandan men was
associated with an increase in highly HIV-susceptible T cell subsets in the blood, but not the
foreskin. Whether these immune changes would alter HIV susceptibility, given that they are
limited to the blood compartment, is not clear. Future studies are warranted to determine if the
systemic immune changes observed in this study extend to other mucosal sites of HIV acquisi-
tion, such as the cervicovaginal or gut mucosae.
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